Back to newsRoyalty Pharma: Morgan Stanley raises target price to $75 from $67RRPRX•2026-11-05Morgan Stanley raised its target price for Royalty Pharma to $75 from $67.Related NewsTTutor Perini Corporation: UBS raises target price to $107 from $105TPC•2026-11-05GAMEX halts trading in GNMXGNMX•2026-11-05XUS upstream M&A value climbs to $12.6 billion in third quarter, Enverus saysXLE•2026-11-05AApple reportedly seeks about $7 billion from bond saleAAPL•2026-11-05HWarrior Met Coal target price cut to $97 from $102HCC•2026-11-05
RPRX•RPRX•RPRX•RPRX•
